NCT04383223

Brief Summary

Youth living with HIV are at high risk of falling out of care when they transition from pediatric to adult care. The investigators are proposing to develop a mobile app to help both clinical providers and patients navigate this process.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 7, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 12, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

August 28, 2020

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

August 13, 2025

Completed
Last Updated

August 13, 2025

Status Verified

August 1, 2025

Enrollment Period

3.8 years

First QC Date

May 7, 2020

Results QC Date

June 27, 2025

Last Update Submit

August 8, 2025

Conditions

Keywords

HIV

Outcome Measures

Primary Outcomes (1)

  • Linkage to Adult Care

    Defined dichotomously as having one completed adult clinic appointment or not.

    18 month post-intervention

Secondary Outcomes (2)

  • Care Retention Per Each 6-month Period

    Baseline, 6 month post-intervention, 12 month post-intervention, 18-month post-intervention

  • Number of Participants With Viral Suppression

    Baseline, 1-year post-intervention

Study Arms (4)

YLH Historical Control Group

NO INTERVENTION

Participants in this group will have the following phases: * Screening * Single visit assessment

YLH iTransition Intervention Group

EXPERIMENTAL

Participants in this group will have the following phases: * Screening * Baseline Visit * Follow-Up visits at 6, 12 and 18 month * Interview visits for selected YLH around 3 and 9 month

Behavioral: iTransition

Provider Group

EXPERIMENTAL

Participants in this group will have the following phases: * Screening * Baseline Visit * Follow-Up visits at 6, 12 and 18 month * Interview visits for selected YLH around 3, 9 and 15 month

Behavioral: iTransition

Transition Champion Group

EXPERIMENTAL

Participants in this group will have the following phases: * Screening * Baseline Visit and Follow-Up visits at 6, 12 and 18 month * Interview visits for selected YLH around 3, 9 and 15 month

Behavioral: iTransition

Interventions

iTransitionBEHAVIORAL

Is a mobile website application (app), and it can be used on a range of devices (computer, tablet, smartphone) and operating systems (iOS, Android, Windows). Features of iTransition will include, but are not limited to: medication reminders, calendar tracking of appointments, direct messaging between youth and providers, and privacy password lock.

Provider GroupTransition Champion GroupYLH iTransition Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • For YLH Historical Control Group
  • YLH (regardless of gender/assigned sex at birth) age ≥ 18 years;
  • Has plan for HCT within next 6 months;
  • Enrolled in care at Grady IDP pediatric/adolescent clinic or CHOP AI/SI clinics.
  • For YLH iTransition Intervention Group
  • YLH (regardless of gender/assigned sex at birth) age ≥ 18 years;
  • Has plan for HCT within next 6 months;
  • Enrolled in care at Grady IDP pediatric/adolescent clinic or CHOP AI/SI clinics;
  • Owns a smartphone and/or tablet
  • Reports consistent internet access (defined as no lapse \>24 hours in last 6 months) via their smartphone or tablet.
  • For Provider Group
  • Staff member at Grady IDP (pediatric/adolescent clinic, adult women's clinic, and/or adult men's clinic), CHOP AI/SI clinics, UPHS: HUP or Presby infectious disease clinics;
  • Works with transitioning YLH;
  • Access to internet via any device (e.g., smartphone, tablet, computer);
  • Endorse participation in the HCT process.
  • +6 more criteria

You may not qualify if:

  • Youth who are \<18 years old;
  • Youth who are not living with HIV;
  • Transition is not expected (from pediatric/adolescent to adult care) within the next 6 months;
  • Presence of serious psychiatric symptoms (e.g., active hallucinations, thought disorder) that would impair the individual's ability to provide true informed consent or participate in the study activities;
  • Visibly distraught (e.g., suicidal, homicidal, exhibiting violent behavior) at the time of consent.
  • For YLH iTransition Intervention Group
  • Youth who are \<18 years old;
  • Youth who are not living with HIV;
  • Transition is not expected (from pediatric to adult care) within the next 6 months;
  • Does not own smartphone/tablet and has inconsistent internet access (i.e. has had one or more lapse \>24 hrs in the last three months);
  • Presence of serious psychiatric symptoms (e.g., active hallucinations, thought disorder) that would impair the individual's ability to provide true informed consent or participate in the study activities;
  • Visibly distraught (e.g., suicidal, homicidal, exhibiting violent behavior) at the time of consent.
  • For Provider Group
  • Not a staff member at Grady IDP, CHOP SI/AI, UPHS: HUP or Presby infectious disease clinics;
  • Does not work with transitioning YLH;
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Grady Hospital

Atlanta, Georgia, 30303, United States

Location

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104, United States

Location

University of Pennsylvania Health System - HUP and Presby infectious disease clinics

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

Acquired Immunodeficiency SyndromeHIV Seropositivity

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Results Point of Contact

Title
Dr. Sophia Hussen
Organization
Emory University

Study Officials

  • Sophia Hussen, MD

    Emory University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 7, 2020

First Posted

May 12, 2020

Study Start

August 28, 2020

Primary Completion

June 30, 2024

Study Completion

June 30, 2024

Last Updated

August 13, 2025

Results First Posted

August 13, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

Survey data will be shared as well as de-identified clinical outcome data Study protocols and statistical analysis plans upon request

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Data is expected to become available in September 2022 upon completion of the study.
Access Criteria
Data will not be deposited into a public repository, but will be made available upon request to the principal investigator. The PI will discuss requests with the other study team members, and make a determination about whether data can be shared.

Locations